Ligand bias at metabotropic glutamate 1a receptors: Molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling

Molecular Pharmacology

Volumn 82, Issue 2, 2012, Pages 291-301

  Emery, Andrew C ^a   DiRaddo, John O ^a   Miller, Eric ^b   Hathaway, Hannah A ^a   Pshenichkin, Sergey ^a   Takoudjou, Guy Rodrigue ^a   Grajkowska, Ewa ^a   Yasuda, Robert P ^a   Wolfe, Barry B ^a   Wroblewski, Jarda T ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIHYDROXYPHENYLGLYCINE; 4 CARBOXY 2 METHYLPHENYLGLYCINE; ASPARTIC ACID; BETA ARRESTIN; CYSTEIC ACID; GLUTAMIC ACID; GLUTARIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; METABOTROPIC GLUTAMATE 1A RECEPTOR; METABOTROPIC RECEPTOR 1; PHOSPHATIDYLINOSITIDE; QUISQUALIC ACID; SUCCINIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HUMAN; HYDROLYSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, METABOTROPIC GLUTAMATE; SIGNAL TRANSDUCTION;

EID: 84863928803     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.078444     Document Type: Article

References (29)

1. Acher FC, Selvam C, Pin JP, Goudet C, and Bertrand HO (2011) A critical pocket close to the glutamate binding site of mGlu receptors opens new possibilities for agonist design. Neuropharmacology 60:102-107.
2. Aramori I and Nakanishi S (1992) Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells. Neuron 8:757-765.
3. Bruno V, Copani A, Battaglia G, Raffaele R, Shinozaki H, and Nicoletti F (1994) Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death. Eur J Pharmacol 256:109-112.
4. Choe ES and Wang JQ (2001) Group I metabotropic glutamate receptor activation increases phosphorylation of cAMP response element-binding protein, Elk-1, and extracellular signal-regulated kinases in rat dorsal striatum. Brain Res Mol Brain Res 94:75-84.
5. Clark BP, Baker SR, Goldsworthy J, Harris JR, and Kingston AE (1997) (+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors. Bioorg Med Chem Lett 7:2777-2780.
6. Conn PJ and Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237.
7. Emery AC, Pshenichkin S, Takoudjou GR, Grajkowska E, Wolfe BB, and Wroblewski JT (2010) The protective signaling of metabotropic glutamate receptor 1 is mediated by sustained, beta-arrestin-1-dependent ERK phosphorylation. J Biol Chem 285:26041-26048.
8. Fisher A, Heldman E, Gurwitz D, Haring R, Barak D, Meshulam H, Marciano D, Brandeis R, Pittel Z, and Segal M (1993) Selective signaling via unique M1 muscarinic agonists. Ann NY Acad Sci 695:300-303.
9. Karim F, Wang CC, and Gereau RW 4th (2001) Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci 21:3771-3779.
10. Kohara A, Toya T, Tamura S, Watabiki T, Nagakura Y, Shitaka Y, Hayashibe S, Kawabata S, and Okada M (2005) Radioligand binding properties and pharmacological characterization of 6-amino-N-cyclohexyl-N,3-dimethylthiazolo[3, 2-a]benzimidazole-2-carboxamide (YM-298198), a high-affinity, selective, and noncompetitive antagonist of metabotropic glutamate receptor type 1. J Pharmacol Exp Ther 315:163-169.
11. Kreibich TA, Chalasani SH, and Raper JA (2004) The neurotransmitter glutamate reduces axonal responsiveness to multiple repellents through the activation of metabotropic glutamate receptor 1. J Neurosci 24:7085-7095.
12. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, and Morikawa K (2000) Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407:971-977.
13. Mehlen P and Bredesen DE (2004) The dependence receptor hypothesis. Apoptosis 9:37-49.
14. Moroni F, Attucci S, Cozzi A, Meli E, Picca R, Scheideler MA, Pellicciari R, Noe C, Sarichelou I, and Pellegrini-Giampietro DE (2002) The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death. Neuropharmacology 42:741-751.
15. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
16. Ogawa H, Qiu Y, Philo JS, Arakawa T, Ogata CM, and Misono KS (2010) Reversibly bound chloride in the atrial natriuretic peptide receptor hormone-binding domain: possible allosteric regulation and a conserved structural motif for the chloridebinding site. Protein Sci 19:544-557.
17. Pin JP and Duvoisin R (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34:1-26.
18. Pshenichkin S, Dolińska M, Klauzińska M, Luchenko V, Grajkowska E, and Wroblewski JT (2008) Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation: possible role as a dependence receptor. Neuropharmacology 55:500-508.
19. Rajagopal S, Rajagopal K, and Lefkowitz RJ (2010) Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 9:373-386.
20. Sato T, Shimada Y, Nagasawa N, Nakanishi S, and Jingami H (2003) Amino acid mutagenesis of the ligand binding site and the dimer interface of the metabotropic glutamate receptor 1: identification of crucial residues for setting the activated state. J Biol Chem 278:4314-4321.
21. Siliprandi R, Lipartiti M, Fadda E, Sautter J, and Manev H (1992) Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity. Eur J Pharmacol 219:173-174.
22. Storozheva ZI, Proshin AT, Sherstnev VV, Storozhevykh TP, Senilova YE, Persi-yantseva NA, Pinelis VG, Semenova NA, Zakharova EI, and Pomytkin IA (2008) Dicholine salt of succinic acid, a neuronal insulin sensitizer, ameliorates cognitive deficits in rodent models of normal aging, chronic cerebral hypoperfusion, and beta-amyloid peptide-(25-35)-induced amnesia. BMC Pharmacol 8:1.
23. Thandi S, Blank JL, and Challiss RA (2002) Group-I metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to extracellular signal-regulated kinase (ERK) activation via distinct, but overlapping, signalling pathways. J Neurochem 83:1139-1153.
24. Vanderklish PW and Edelman GM (2002) Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons. Proc Natl Acad Sci USA 99:1639-1644.
25. Versteeg HH, Nijhuis E, van den Brink GR, Evertzen M, Pynaert GN, van Deventer SJ, Coffer PJ, and Peppelenbosch MP (2000) A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem J 350:717-722.
26. Violin JD and Lefkowitz RJ (2007) Beta-arrestin-biased ligands at seventransmembrane receptors. Trends Pharmacol Sci 28:416-422.
27. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM, and Lefkowitz RJ (2003) Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci USA 100:10782-10787.
28. Zhang F, Klebansky B, Fine RM, Liu H, Xu H, Servant G, Zoller M, Tachdjian C, and Li X (2010) Molecular mechanism of the sweet taste enhancers. Proc Natl Acad Sci USA 107:4752-4757.
29. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, and Bredesen DE (1993) bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 90:4533-4537.